Revision history of "Realworld efficacy of brentuximab vedotin as well as bendamustine like a connection in order to autologous hematopoietic stem mobile or portable transplantation within principal refractory as well as relapsed traditional Hodgkin lymphoma"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 11:26, 24 April 2024‎ Tripanswer8 (Talk | contribs)‎ . . (3,501 bytes) (+3,501)‎ . . (Created page with "These studies prospectively examined your serialized HR-QoL in TE-MM while using EORTC QLQ-C30 and also MY20 questionnaires. Barring the particular short-term difficult in QoL...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Realworld_efficacy_of_brentuximab_vedotin_as_well_as_bendamustine_like_a_connection_in_order_to_autologous_hematopoietic_stem_mobile_or_portable_transplantation_within_principal_refractory_as_well_as_relapsed_traditional_Hodgkin_lymphoma"